COGT (Cogent Biosciences) OCF Yield %: -4.44 (As of Jun. 24, 2026)


COGT Cogent Biosciences Inc COGT
25 GF Score
Price $37.53
! 3 Warning Signs
View Full Analysis

What is Cogent Biosciences OCF Yield %?

Cogent Biosciences COGT +3.36% 25 OCF Yield % is -4.44 as of Jun. 24, 2026. GuruFocus rates COGT with a GF Score™ of 25/100. The stock has 3 warning signs investors should review. Among 1,418 Biotechnology companies, Cogent Biosciences ranks better than 59.66% on this metric.

OCF Yield % is calculated as Cash Flow from Operations divided by Market Capitalization. It is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

As of today, Cogent Biosciences's Trailing 12-Month Cash Flow from Operations is $-284.82 Mil, and Market Cap is $6,412.68 Mil. Therefore, Cogent Biosciences's OCF Yield % for today is -4.44%.

The historical rank and industry rank for Cogent Biosciences's OCF Yield % or its related term are showing as below:

COGT' s OCF Yield % Range Over the Past 10 Years
Min: -419.66   Med: -13.69   Max: -2.69
Current: -4.44


During the past 11 years, the highest OCF Yield % of Cogent Biosciences was -2.69%. The lowest was -419.66%. And the median was -13.69%.

COGT's OCF Yield % is ranked better than
59.66% of 1418 companies
in the Biotechnology industry
Industry Median: -8.55 vs COGT: -4.44

Cogent Biosciences's OCF Margin % for the quarter that ended in Mar. 2026 was %.


Cogent Biosciences OCF Yield % Explanation

Similar to Earnings Yield %, OCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high operating cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.


Cogent Biosciences OCF Yield % Related Terms


Cogent Biosciences OCF Yield % Historical Data

* Premium members only.

The historical data trend for Cogent Biosciences's OCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Cogent Biosciences OCF Yield % Chart

Cogent Biosciences Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Yield %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -15.63 -14.68 -30.34 -24.12 -4.62

Cogent Biosciences Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Yield % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -39.01 -26.67 -12.81 -5.53 -5.29

COGT vs SRRK, RYTM, PTCT: OCF Yield % Comparison

For the Biotechnology subindustry, Cogent Biosciences's OCF Yield %, along with its competitors' market caps and OCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cogent Biosciences OCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cogent Biosciences's OCF Yield % distribution charts can be found below:

* The bar in red indicates where Cogent Biosciences's OCF Yield % falls into.


COGT
25GF Score
Cogent Biosciences Inc COGT
OCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Cogent Biosciences OCF Yield % Calculation

OCF Yield % is a financial solvency ratio that compares the operating cash flow a company is expected to earn against its market value.

Cogent Biosciences's OCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

OCF Yield %=Cash Flow from Operations / Market Cap
=-264.444 / 5718.0096
=-4.62%

Cogent Biosciences's annualized OCF Yield % for the quarter that ended in Mar. 2026 is calculated as

OCF Yield %=Cash Flow from Operations * Annualized Factor / Market Cap
=-86.883 * 4 / 6573.09126
=-5.29%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Yield % →
What does a OCF Yield % of -4.44 mean?
Cogent Biosciences (COGT) has a OCF Yield % of -4.44 as of Jun. 24, 2026. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cogent Biosciences and its competitors. According to the industry distribution chart, Cogent Biosciences ranks #572 out of 1418 companies in the Biotechnology industry, placing it in the top 40.3%.
Is Cogent Biosciences' OCF Yield % too high?
Cogent Biosciences' current OCF Yield % is -4.44. Based on the distribution chart, Cogent Biosciences ranks #572 out of 1418 companies in the Biotechnology industry, which is above the industry midpoint. Overall, Cogent Biosciences has a GF Score™ of 25/100, reflecting its overall financial health beyond just this single metric.
How does Cogent Biosciences' OCF Yield % compare to SRRK and RYTM?
According to the Biotechnology industry distribution chart, Cogent Biosciences ranks #572 out of 1418 companies for OCF Yield %. This puts Cogent Biosciences in the upper half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Yield % for a Biotechnology company?
A good OCF Yield % depends on the Biotechnology industry context. However, OCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Yield % mean?
A high OCF Yield % can signal that a stock is expensive relative to its fundamentals. OCF Yield is calculated as Cash Flow from Operations divided by Market Capitalization. View historical data on Cogent Biosciences and its competitors. Cogent Biosciences's current OCF Yield % is -4.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Cogent Biosciences stock overvalued right now?
Cogent Biosciences (COGT) has a current OCF Yield % of -4.44. The current OCF Yield % is -4.44. Cogent Biosciences' overall GF Score™ is 25/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Yield % calculated?
OCF Yield % is calculated from a company's financial statements. For Cogent Biosciences (COGT), the current OCF Yield % is -4.44 as of Jun. 24, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Cogent Biosciences Business Description

Address 275 Wyman Street, 3rd Floor, Waltham, MA, USA, 02451
Cogent Biosciences Inc a biotechnology company focused on developing precision therapies for genetically defined diseases. It designs rational precision therapies that treat the underlying cause of disease and improve the lives of patients. Its program CGT9486, is a selective tyrosine kinase inhibitor designed to potently inhibit the KIT D816V mutation as well as other mutations in KIT exon 17. In the vast majority of cases, KIT D816V is responsible for driving Systemic Mastocytosis (SM), a serious disease caused by the unchecked proliferation of mast cells. Exon 17 mutations are also found in patients with advanced gastrointestinal stromal tumors (GIST), a type of cancer with dependence on oncogenic KIT signaling.
25GF Score

Get the complete analysis for COGT

OCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$37.53
Price